tiprankstipranks
Advertisement
Advertisement

JP:4882 Stock Latest News

Perseus Proteomics Reports Durable Phase I Follow-Up Results for PPMX-T003 in Polycythemia Vera
Company AnnouncementsPerseus Proteomics Reports Durable Phase I Follow-Up Results for PPMX-T003 in Polycythemia Vera
1d ago
4882
Perseus Proteomics Corrects Cash Flow Figures in FY2026 Results
PremiumCompany Announcements
Perseus Proteomics Corrects Cash Flow Figures in FY2026 Results
10d ago
4882
Perseus Proteomics Overhauls Board, Taps New Director to Lead Business Development
PremiumCompany Announcements
Perseus Proteomics Overhauls Board, Taps New Director to Lead Business Development
1M ago
4882
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in FY2026
PremiumCompany Announcements
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in FY2026
2M ago
4882
Perseus Proteomics Narrows Losses but Withholds FY2027 Forecast Amid Funding Dependence
PremiumCompany Announcements
Perseus Proteomics Narrows Losses but Withholds FY2027 Forecast Amid Funding Dependence
2M ago
4882
Perseus Proteomics Wins AMED Grant to Advance PPMX-T003 for Rare Leukemia
PremiumCompany AnnouncementsPerseus Proteomics Wins AMED Grant to Advance PPMX-T003 for Rare Leukemia
3M ago
4882
Perseus Proteomics Sets FY2026 Forecast, Stays in Red as Licensing Push Continues
Premium
Company Announcements
Perseus Proteomics Sets FY2026 Forecast, Stays in Red as Licensing Push Continues
3M ago
4882
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q3
Premium
Company Announcements
Perseus Proteomics Books Subsidy Income but Suffers Asset Impairment in Q3
5M ago
4882
Perseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn
PremiumCompany Announcements
Perseus Proteomics Narrows Losses but Withholds Full-Year Forecast Amid Ongoing Cash Burn
5M ago
4882
Perseus Proteomics Partners with Eurus Therapeutics for Antibody Research
PremiumCompany Announcements
Perseus Proteomics Partners with Eurus Therapeutics for Antibody Research
7M ago
4882
Perseus Proteomics Extends Clinical Trial for ANKL Treatment
PremiumCompany Announcements
Perseus Proteomics Extends Clinical Trial for ANKL Treatment
8M ago
4882
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
PremiumCompany Announcements
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
8M ago
4882
Perseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
PremiumCompany AnnouncementsPerseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
8M ago
4882
Perseus Proteomics Reports Q1 FY2026 Progress and Financial Growth
Premium
Company Announcements
Perseus Proteomics Reports Q1 FY2026 Progress and Financial Growth
11M ago
4882
Perseus Proteomics Reports Q1 Financial Results with Continued Losses
Premium
Company Announcements
Perseus Proteomics Reports Q1 Financial Results with Continued Losses
11M ago
4882
Perseus Proteomics Announces Capital Restructuring to Strengthen Financial Base
PremiumCompany Announcements
Perseus Proteomics Announces Capital Restructuring to Strengthen Financial Base
1y ago
4882
Perseus Proteomics Inc. Announces Change in Accounting Auditor
PremiumCompany Announcements
Perseus Proteomics Inc. Announces Change in Accounting Auditor
1y ago
4882
Perseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
PremiumCompany Announcements
Perseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
1y ago
4882
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
PremiumCompany Announcements
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
1y ago
4882
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
PremiumCompany AnnouncementsPerseus Proteomics Completes Phase I Trial Report for PPMX-T003
1y ago
4882
Perseus Proteomics Updates PPMX-T003 Project Details
Premium
Company Announcements
Perseus Proteomics Updates PPMX-T003 Project Details
1y ago
4882
Perseus Proteomics’ PPMX-T003 Gains Support for Orphan Drug Development
Premium
Company Announcements
Perseus Proteomics’ PPMX-T003 Gains Support for Orphan Drug Development
1y ago
4882

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >